Search results for "Mortality"

showing 10 items of 1406 documents

Antipsychotic prescription and mortality in hospitalized older persons

2016

Background: Recent scientific reports have shown that older persons treated with antipsychotics for dementia-related behavioural symptoms have increased mortality. However, the impact of these drugs prescribed during hospitalization has rarely been assessed. We aimed to investigate whether antipsychotics are associated with an increased risk of mortality during hospitalization and at 3-month follow-up in elderly inpatients. Methods: We analyzed data gathered during two waves (2010 and 2012) by the REPOSI (Registro Politerapie Società Italiana Medicina Interna). All new prescriptions of antipsychotic drugs during hospitalization, whether maintained or discontinued at discharge, were collect…

MaleSocio-culturaleOlder personAntipsychoticCognitionEconomicaAntipsychotics; Hospitalization; Mortality; Older persons; Gerontology; Geriatrics and Gerontology; Psychiatry and Mental HealthHumansMortalityPsychomotor AgitationAgedantipsychotics hospitalization mortality older personsAged 80 and overMental DisordersPatient DischargeHospitalizationantipsychoticsItalyantipsychotics; hospitalization; mortality; older personsPsychiatry and Mental Healtholder personsDementiaFemaleGeriatrics and GerontologyGerontologyAntipsychotic Agents
researchProduct

Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute resp…

2022

Contains fulltext : 252214.pdf (Publisher’s version ) (Open Access) BACKGROUND: Geoeconomic variations in epidemiology, the practice of ventilation, and outcome in invasively ventilated intensive care unit (ICU) patients without acute respiratory distress syndrome (ARDS) remain unexplored. In this analysis we aim to address these gaps using individual patient data of four large observational studies. METHODS: In this pooled analysis we harmonised individual patient data from the ERICC, LUNG SAFE, PRoVENT, and PRoVENT-iMiC prospective observational studies, which were conducted from June, 2011, to December, 2018, in 534 ICUs in 54 countries. We used the 2016 World Bank classification to defi…

MaleSociodemographic FactorsRespiration Artificial/methodsARDS ; mechanical ventilationSeverity of Illness IndexNOSettore MED/41 - ANESTESIOLOGIA80 and overTidal VolumeHumansHospital MortalityProspective Studiesddc:610Developing CountriesAgedHospital Mortality/trendsAged 80 and overDeveloped Countries/statistics & numerical dataDeveloping Countries/statistics & numerical dataRespirationDeveloped CountriesArticlesGeneral Medicineacute respiratory distress syndromeLength of StayMiddle AgedRespiration ArtificialIntensive Care UnitsObservational Studies as Topiclnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]Length of Stay/statistics & numerical dataArtificialIntensive Care Units/statistics & numerical dataIncomeFemaleARDS
researchProduct

Some findings on zero-inflated and hurdle Poisson models for disease mapping

2018

Zero excess in the study of geographically referenced mortality data sets has been the focus of considerable attention in the literature, with zero-inflation being the most common procedure to handle this lack of fit. Although hurdle models have also been used in disease mapping studies, their use is more rare. We show in this paper that models using particular treatments of zero excesses are often required for achieving appropriate fits in regular mortality studies since, otherwise, geographical units with low expected counts are oversmoothed. However, as also shown, an indiscriminate treatment of zero excess may be unnecessary and has a problematic implementation. In this regard, we find …

MaleStatistics and ProbabilityDatabases FactualEpidemiologyComputer scienceGeographic MappingEstadísticaBiostatisticsPoisson distribution01 natural sciences010104 statistics & probability03 medical and health sciencessymbols.namesakeSpatio-Temporal Analysis0302 clinical medicineNeoplasmsEconometricsHumansPoisson Distribution030212 general & internal medicineLack-of-fit sum of squaresMortality0101 mathematicsProbabilityModels StatisticalBayes TheoremZero (linguistics)SpainMortality datasymbolsMalaltiesFemaleFocus (optics)
researchProduct

Spatial Interaction between Neighbouring Counties: Cancer Mortality Data in Valencia (Spain)

1995

The statistical analysis of geographical mortality data has usually been approached via regression models that include appropriate covariates. These models assume stochastic independence of mortality counts for neighbouring sites, a questionable assumption that spatial automodels (Besag, 1974, Journal of the Royal Statistical Society, Series B 36, 192-236) make unnecessary. This paper presents the use of the autopoisson distribution in order to detect spatial interaction between neighbouring sites. If this interaction results in being nonsignificant, the auto-Poisson distribution reduces to a usual Poisson regression model, a particular case of generalized linear models (McCullagh and Nelde…

MaleStatistics and ProbabilityGeneralized linear modelGLIMPoisson distributionGeneral Biochemistry Genetics and Molecular Biologysymbols.namesakeStomach NeoplasmsNeoplasmsStatisticsCovariateHumansPoisson DistributionPoisson regressionFertilizersDemographyCancer mortalityModels StatisticalNitratesGeneral Immunology and MicrobiologyApplied MathematicsSpatial interactionProstatic NeoplasmsRegression analysisGeneral MedicineGeographyUrinary Bladder NeoplasmsSpainColonic NeoplasmssymbolsRegression AnalysisGeneral Agricultural and Biological SciencesDemographyBiometrics
researchProduct

Effects of clinical and laboratory variables and of pretreatment with cardiovascular drugs in acute ischaemic stroke: A retrospective chart review fr…

2009

Background: Few studies have examined the role of cardiovascular drugs on acute ischaemic stroke prognosis. Aims: To evaluate the relationship between a favourable outcome in patients with acute ischaemic stroke and specific demographic, clinical and laboratory variables and cardiovascular drug pretreatment. Methods: The 1096 patients enrolled in the GIFA study (who had a main discharge diagnosis of ischaemic stroke) represent the final patient sample used in this analysis. Drugs considered in the analysis included angiotensin converting enzyme (ACE)-inhibitors, angiotensin II receptor blockers, statins, calcium channel blockers, anti-platelet drugs, vitamin K antagonists and heparins. The …

MaleStroke prognosis pre-treatmentmedicine.medical_specialtySettore MED/09 - Medicina InternaActivities of daily livingDatabases FactualBrain IschemiaInternal medicineWhite blood cellmedicineHumansHospital MortalityStrokeAgedRetrospective StudiesAged 80 and overbiologybusiness.industryPharmacoepidemiologyCalcium channelCardiovascular AgentsAngiotensin-converting enzymeRetrospective cohort studyHeparinmedicine.diseaseStrokeTreatment Outcomemedicine.anatomical_structureBlood pressureItalybiology.proteinPhysical therapyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up Studiesmedicine.drugInternational Journal of Cardiology
researchProduct

[Italy 2014: 1,000 new cancer cases every day, but mortality is decreasing].

2015

In Italy in 2014 1,000 new cancer cases every day, but mortality is decreasing

MaleSurvival Ratecancer incidenceItalyNeoplasmsHumansFemaleMorbidityMortalitySex Distributioncancer in Italy cancer registriesSettore MED/42 - Igiene Generale E ApplicataEpidemiologia e prevenzione
researchProduct

Oral and oropharyngeal squamous cell carcinoma in young adults: A retrospective study in Granada University Hospital

2017

Background This study aims to evaluate and analyze the clinical features and outcomes of oral and oropharyngeal squamous cell carcinoma (SCC) in patients 45 years were randomly selected from the same database. A retrospective analysis was conducted to determine specific features including sites of occurrence, risk factors, sex distribution, socio-economic status, T stage at diagnosis, nodal involvement, degree of tumor differentiation, locoregional failure and overall survival at 5 years was. Further, the results of both groups were compared. Results The male-female ratio was 1.2:1 in the group of young adults and 2.03:1 in the group of patients with an age of >45 years. No significant diff…

MaleSurvivalDiseaseHospitals UniversityCavity cancers0302 clinical medicineRisk Factorsrisk factorsIncidence trendsMedicineYoung adultTongue cancerMiddle AgedUniversity hospital:CIENCIAS MÉDICAS [UNESCO]Risk-factorsOropharyngeal NeoplasmsHead and Neck Neoplasms030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASCarcinoma Squamous CellFemaleMouth Neoplasmsyoung adultsAdultmedicine.medical_specialtyMEDLINE03 medical and health sciencesAgeInternal medicineCarcinomaHumansMortalityGeneral DentistrySurvival rateOral and oropharyngeal squamous cell carcinomaRetrospective StudiesOral Medicine and PathologyNeck-cancer incidencebusiness.industrySquamous Cell Carcinoma of Head and NeckResearchPeopleRetrospective cohort study030206 dentistrypoor prognosismedicine.diseaseSurgeryOtorhinolaryngologySpainT-stageSurgerybusinessHeadMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Changes in disease burden in Poland between 1990-2017 in comparison with other Central European countries: A systematic analysis for the Global Burde…

2020

Background Systematic collection of mortality/morbidity data over time is crucial for monitoring trends in population health, developing health policies, assessing the impact of health programs. In Poland, a comprehensive analysis describing trends in disease burden for major conditions has never been published. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides data on the burden of over 300 diseases in 195 countries since 1990. We used the GBD database to undertake an assessment of disease burden in Poland, evaluate changes in population health between 1990–2017, and compare Poland with other Central European (CE) countries. Methods The results of GBD 2017 for …

MaleSystems AnalysisPulmonology030204 cardiovascular system & hematologyGlobal HealthPathology and Laboratory MedicineGeographical locationsGlobal Burden of DiseaseSelf Harm0302 clinical medicineEndocrinologySex factorsRisk FactorsGlobal healthMedicine and Health SciencesMedicinePublic and Occupational Health030212 general & internal medicineChild2. Zero hungerAged 80 and overMultidisciplinaryOrganic CompoundsQ1. No povertyRMiddle Aged3. Good healthEuropeChemistryChild PreschoolPhysical SciencesMedicineFemaleQuality-Adjusted Life YearsResearch ArticleBurden of diseaseAdultCross-Cultural ComparisonAdolescentEndocrine DisordersChronic Obstructive Pulmonary DiseaseScienceLower Back PainMEDLINEPainPopulation health03 medical and health sciencesYoung AdultSigns and SymptomsLife ExpectancySex FactorsDiagnostic MedicineEnvironmental healthburden of disease Poland epidemiologyMental Health and PsychiatryDiabetes MellitusHumansEuropean UnionDisease burdenAgedbusiness.industryMortality PrematureOrganic ChemistryChemical CompoundsInfant NewbornInfantQuality-adjusted life yearAlcoholsMetabolic DisordersPolandPeople and placesbusinessPLoS ONE
researchProduct

Fruit and Vegetable Consumption is Inversely Associated with Plasma Saturated Fatty Acids at Baseline in Predimed Plus Trial

2021

I.D.-L. is supported by the [FI_B 00256] from the FI-AGAUR Research Fellowship Program, Generalitat de Catalunya and M.M.-M is supported by the FPU17/00513 grant. a.-H. is supported by the [CD17/00122] grant and S.K.N. is supported by a Canadian Institutes of Health Research (CIHR) Fellowship. We also thank all the volunteers for their participation in and the personnel for their contribution to the PREDIMED-Plus trial. This research was funded by CiCYT [AGL2016-75329-R] and CIBEROBN from the Instituto de Salud Carlos III, ISCIII from the Ministerio de Ciencia, Innovacion y Universidades, (AEI/FEDER, UE), Generalitat de Catalunya (GC) [2017SGR196]. The PREDIMED-Plus trial was supported by t…

MaleSíndrome metabòlica030309 nutrition & dieteticsgovernment.political_districtdigestionDiet Mediterranean0302 clinical medicineVegetablesDietary fatDietary fatsriskMetabolic Syndrome2. Zero hunger0303 health sciencesBalearic islandsEuropean researchFatty AcidsMiddle AgedMetabolic syndromeOils and fats EdibleCardiovascular diseasesFemalegenetic-variationmediterranean populationfiberBiotechnology030209 endocrinology & metabolismlipids03 medical and health sciencesPolitical scienceOlis i greixos comestiblesMediterranean dietCuina mediterràniaCooking MediterraneanHumansMUFAAgeddietary-fatdiseaseMalalties cardiovascularsPREDIMED-Plusdietary fatsmortalityPredimedCross-Sectional StudiesFruitgovernmentEdible oils and fatsEnergy IntakeabsorptionHumanitiesPUFAdietary fats Mediterranean dietFood ScienceOlive oil
researchProduct

Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People

2016

Aims: The objective of this study was to evaluate the prevalence of the prescription of QT-prolonging drugs at hospital admission and discharge and the risk factors associated with their use in older people (aged 65 years and older). Methods: Data were obtained from the REPOSI (REgistro POliterapie SIMI [Società Italiana di Medicina Interna]) registry, which enrolled 4035 patients in 2008 (n = 1332), 2010 (n = 1380), and 2012 (n = 1323). Multivariable logistic regression was performed to determine the risk factors independently associated with QT-prolonging drug use. QT-prolonging drugs were classified by the risk of Torsades de Pointes (TdP) (definite, possible, or conditional) acc…

MaleTORSADES-DE-POINTES INTERVAL PROLONGATION PATIENT CIPROFLOXACIN COHORT DEATH MULTIMORBIDITY AMIODARONE MORTALITY AIFA.Amiodarone030204 cardiovascular system & hematologyCIPROFLOXACINLogistic regressionAmiodaroneElectrocardiography0302 clinical medicineRisk FactorsTorsades de PointesAtrial Fibrillation80 and overPrevalencePharmacology (medical)030212 general & internal medicineAged; Aged 80 and over; Amiodarone; Atrial Fibrillation; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Patient Discharge; Prevalence; Risk Factors; Torsades de Pointes; Hospitalizationmedia_commonAged 80 and overTorsades de PointeAged; Aged 80 and over; Amiodarone; Atrial Fibrillation; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Patient Discharge; Prevalence; Risk Factors; Torsades de Pointes; Hospitalization; Pharmacology (medical); Geriatrics and Gerontology; Medicine (all)Medicine (all)DEATHMiddle AgedPatient DischargeHospitalizationLong QT SyndromeCohortHospitalized Older PeopleFemalemedicine.drugHumanDrugmedicine.medical_specialtymedia_common.quotation_subjectMULTIMORBIDITYTorsades de pointesPATIENT03 medical and health sciencesPharmacotherapyInternal medicineINTERVAL PROLONGATIONmedicineHumansTORSADES-DE-POINTESCOHORTMedical prescriptionAIFAAgedbusiness.industryMORTALITYRisk FactorSettore MED/09 - MEDICINA INTERNAOdds ratiomedicine.diseaseQT-Prolonging DrugAged; Aged 80 and over; Amiodarone; Atrial Fibrillation; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Patient Discharge; Prevalence; Risk Factors; Torsades de Pointes; Hospitalization; Geriatrics and Gerontology; Pharmacology (medical)Physical therapyGeriatrics and Gerontologybusiness
researchProduct